Jason Patrick Meyenburg serves as Executive at Sucampo Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Jason Patrick Meyenburg has executed 3 insider transactions totaling $171.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 14, 2021 involved purchasing 13,000 shares valued at $123.0K.
Jason Patrick Meyenburg currently holds 13,000 shares of Sucampo Pharmaceuticals, Inc. (SCMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Patrick Meyenburg has been a net buyer of SCMP stock. They have purchased $171.5K and sold $0 worth of shares.
Jason Patrick Meyenburg's most recent insider trade was on May 14, 2021, when they purchased 13,000 shares at $9.46 per share.
Get notified when new Form 4 filings are submitted
| $18.00 |
| Discretionary |
| Sep 6, 2017 | SCMP | $48.5K | Purchase | 4,000 | $12.13 | Discretionary |